Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma

Tumor Biology

Volumn 36, Issue 10, 2015, Pages 7409-7422

  Gao, Yunzhen ^a   Chen, Geng ^a   Zeng, Yongyi ^a   Zeng, Jinhua ^a   Lin, Minjie ^a   Liu, Xiaolong ^a   Liu, Jingfeng ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Expression profiles; Hepatocellular carcinoma; Invasion; Long noncoding RNA; Metastasis; Recurrence

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA;

ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE ONTOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER METASTASIS; PRIORITY JOURNAL; TUMOR INVASION; UPREGULATION; CANCER STAGING; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; LYMPH NODE METASTASIS; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY; SIGNAL TRANSDUCTION; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84944275629     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3408-0     Document Type: Article

References (44)

1. Jemal A et al. Global cancer statistics. CA: Cancer J Clin. 2011;2:69–90.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: Cancer J Clin. 2012;1:10–29.
3. Allemani C et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2014. doi:10.1016/S0140-6736(14)62038-9.
4. Rahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW, et al. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg. 2011;3:453–69.
5. Ng KM, Yan T, Black D, Chu FC, Morris DL. Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma. HPB (Oxford). 2009;4:311–20.
6. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;6:904–14.
7. Huang J-l, Zheng L, Hu Y-W. Characteristics of long noncoding RNA and its relation to hepatocellular carcinoma. Carcinogenesis. 2014;3:507–14.
8. Ernst C, Morton CC. Identification and function of long non-coding RNA. Front Cell Neurosci. 2013. doi:10.3389/fncel.2013.00168.
9. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;4:629–41.
10. Quagliata L et al. LncRNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. 2013;3:911–23.
11. Panzitt K et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007;1:330–42.
12. Wang J et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010;16:5366–83.
13. Yang F et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 2011;5:1679–89.
14. Yuan J-H et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014;5:666–81.
15. Wang F, Yuan J-H, Wang S-B, Yang F, Yuan S-X, Ye C, et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology. 2014;4:1278–90.
16. Yu W et al. Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells. Cell Signal. 2014;12:2961–8.
17. Ørom UA et al. Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010;1:46–58.
18. Barabási A-L, Oltvai ZN. Network biology: understanding the cell’s functional organization. Nat Rev Genet. 2004;2:101–13.
19. Dinger ME et al. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res. 2008;9:1433–45.
20. Mercer TR et al. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. BMC Neurosci. 2010. doi:10.1186/1471-2202-11-14.
21. Carninci P et al. The transcriptional landscape of the mammalian genome. Science. 2005;5740:1559–63.
22. Wang X et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature. 2008;7200:126–30.
23. Faghihi MA, Wahlestedt C. Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol. 2009;9:637–43.
24. Louro R et al. Conserved tissue expression signatures of intronic noncoding RNAs transcribed from human and mouse loci. Genomics. 2008;1:18–25.
25. Louro R, Smirnova AS, Verjovski-Almeida S. Long intronic noncoding RNA transcription: expression noise or expression choice? Genomics. 2009;4:291–8.
26. Trinklein ND et al. An abundance of bidirectional promoters in the human genome. Genome Res. 2004;1:62–6.
27. Morris KV et al. Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet. 2008;11:e1000258.
28. Liu J et al. Genome-wide analysis uncovers regulation of long intergenic noncoding RNAs in Arabidopsis. Plant Cell Online. 2012;11:4333–45.
29. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;6:703–19.
30. Prensner JR et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol. 2011;8:742–9.
31. Gupta RA et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;7291:1071–6.
32. Gutschner T, Hämmerle M, Diederichs S. MALAT1—a paradigm for long noncoding RNA function in cancer. J Mol Med. 2013;7:791–801.
33. Braconi C et al. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci. 2011;2:786–91.
34. Huang JF et al. Hepatitis B virus X protein (HBx)-related long noncoding RNA (LncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology. 2013;5:1882–92.
35. Yang F et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell. 2013;6:1083–96.
36. Tsang WP, Kwok T. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells. Oncogene. 2007;33:4877–81.
37. Zhu J et al. The long noncoding RNA expression profile of hepatocellular carcinoma identified by microarray analysis. PLoS One. 2014;9(7):e101707.
38. Kutter C et al. Rapid turnover of long noncoding RNAs and the evolution of gene expression. PLoS Genet. 2012;7:e1002841.
39. Derrien T et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;9:1775–89.
40. Liu L et al. Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling. Hepatology. 2013;2:531–43.
41. Jiang D-K et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet. 2012;1:72–5.
42. Jiang J-H et al. An X-chromosomal association study identifies a susceptibility locus at Xq22. 1 for hepatitis B virus-related hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2013;6:586–95.
43. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;3:155–9.
44. Sulzmaier FJ, Ramos JW. RSK isoforms in cancer cell invasion and metastasis. Cancer Res. 2013;20:6099–105.